Estimating the individual benefit of immediate treatment or active surveillance for prostate cancer after screen-detection in older (65+) men-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Estimating the individual benefit of immediate treatment or active surveillance for prostate cancer after screen-detection in older (65+) men

Published:2016-02-01 Issue:10 Volume:138 Page:2522-2528
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

de Carvalho Tiago M.¹,Heijnsdijk Eveline A.M.¹,de Koning Harry J.¹

Affiliation:

1. Department of Public Health; Erasmus Medical Center; Rotterdam The Netherlands

Funder

National Cancer Institute as part of the Cancer Intervention and Surveillance Modeling Network (CISNET)

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ijc.29976/fullpdf

Reference26 articles.

1. Lead Time and Overdiagnosis in Prostate-Specific Antigen Screening: importance of Methods and Context;Draisma;J Natl Cancer Inst,2009

2. Overdiagnosis in Cancer;Welch;J Natl Cancer Inst,2010

3. Mortality Results after 13 years of Follow-up. Mortality results from a randomized prostate-cancer screening trial;Andriole;N Engl J Med,2009

4. Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up;Schröder;Lancet,2014

5. Preventive Services Task Force. US. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement;Moyer;Ann Intern Med,2012

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Number-needed-to-treat analysis of clinical progression in patients with metastatic castration-resistant prostate cancer in the STRIVE and TERRAIN trials;BMC Urology;2018-09-06

2. Active surveillance: a review of risk-based, dynamic monitoring;Translational Andrology and Urology;2018-02

3. When should active surveillance for prostate cancer stop if no progression is detected?;The Prostate;2017-04-17

4. Prévalence et diversité de la prise en charge des patients atteints de cancer de la prostate classés à faible risque selon la classification de d’Amico ou le score de CAPRA : étude française multicentrique;Progrès en Urologie;2017-03

5. Determining Focal Therapy Failure and Salvage Options;Imaging and Focal Therapy of Early Prostate Cancer;2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3